Kryeziu K, Klokkerud SK, Totland MZ, Moosavi SH, Reims HM, Bergsland CH, Eilertsen IA, Smeby J, Lassen K, Lundesgaard KK, Syversveen T, Brændengen M, Nesbakken A, Guren TK, Yaqub S, Sveen A, Lothe RA(2026) Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity Cell Rep Med, 102840(in press) DOI 10.1016/j.xcrm.2026.102840, PubMed 42208542
Ailte I, Chauhan SK, Prasmickaite L, Bassarova AV, Poissonnier A, Feenstra M, Nyakas M, Johannessen B, Ryder T, Hermann R, Frich L, Holth A, Inderberg EM, Jespersen H, Flørenes VA, Kyte JA, Mælandsmo GM, Egeland EV(2026) CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade Front Oncol, 16, 1815008 DOI 10.3389/fonc.2026.1815008, PubMed 42158424
Vedeld HM, Breder S, Pharo H, Brodal HP, Adolfsen EM, Brandt-Winge S, von Seth E, Grimsrud MM, Yaqub S, Karlsen TH, Grzyb K, Paulsen V, Färkkilä MA, Bergquist A, Aabakken L, Boberg KM, Folseraas T, Lind GE(2026) Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis by DNA methylation biomarkers in bile and plasma JHEP Rep, 101876(in press) DOI 10.1016/j.jhepr.2026.101876, PubMed 42067191
